Movetis is formerly owned by Sofinnova Partners, through Sofinnova Capital VI, since 2008.

When did Sofinnova Partners acquire Movetis?

Sofinnova Partners acquired Movetis in 2008 and exited after 2 years.

Has Movetis been sold?

Yes. Movetis was exited in 2010.

Home/Companies/Biotech/Movetis

Movetis

Biotech·

Belgium·Exited 2010·Held 2yr

Movetis is a healthcare / biotech company, headquartered in Belgium.

Entry

2008

Hold

2yr

Exit

2010

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQBelgium

SectorHealthcare / Biotech

Belgian company focused on GI disease drugs including prucalopride, acquired by Shire in 2010 for EUR 428 million.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Capital VI

Other portfolio companies in the same fund.

Omthera Pharmaceuticals

Exited 2013

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings